Patent ID: 9427463
Filing Date: 2016-08-30
CPC Classification: A61K,A61P,C07K

Claim Text:
1. A method of treating a carcinoma or melanoma in a subject in need thereof, wherein the subject has been diagnosed with the carcinoma or melanoma, consisting essentially of: providing an mTOR inhibitor, wherein the mTOR inhibitor is selected from the group consisting of (i) temsirolimus (CCI-779) or a pharmaceutical equivalent, analog, derivative or a salt thereof, (ii) Everolimus (RAD001) or a pharmaceutical equivalent, analog, derivative or a salt thereof, and (iii) Rapamycin or a pharmaceutical equivalent, analog, derivative or a salt thereof; providing an anti-CD4 antibody or an antigen-binding fragment thereof; administering a therapeutically effective amount of the mTOR inhibitor to the subject; and administering a therapeutically effective amount of the anti-CD4 antibody or an antigen-binding fragment thereof to the subject, so as to treat the carcinoma or melanoma.